<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR38">
 <label>38.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Jacob</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Muppidi</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Guidon</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Guptill</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Hehir</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Howard</surname>
    <given-names>JF</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic</article-title>
  <source>J Neurol Sci</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1016/j.jns.2020.116803</pub-id>
  <?supplied-pmid 32428758?>
  <pub-id pub-id-type="pmid">32428758</pub-id>
 </element-citation>
</ref>
